Related Experiment Video
Updated: Jun 13, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Perspectives in adjuvant chemotherapy in NSCLC
Giovanni Selvaggi1, Giorgio Vittorio Scagliotti
1University of Turin, Department of Clinical & Biological Sciences, Thoracic Oncology Unit, San Luigi Hospital, Regione Gonzole 10, 10043 Orbassano Torino, Italy. gselvaggi@inwind.it
Expert Review of Respiratory Medicine
|May 19, 2010
Summary
Lung cancer survival remains poor, but chemotherapy and surgical advances offer improvements. Future adjuvant treatments require pharmacogenomic profiling for personalized patient selection.
Area of Science:
- Oncology
- Thoracic Surgery
- Pharmacogenomics
Background:
- Lung cancer survival rates remain suboptimal, with a 5-year survival below 15% as of 2007.
- Recent decades show modest survival improvements driven by enhanced surgical techniques and novel chemotherapeutic agents.
Purpose of the Study:
- To review the current landscape of adjuvant chemotherapy for lung cancer.
- To highlight the need for personalized treatment strategies based on molecular markers and pharmacogenomics.
Main Methods:
- Review of recent advancements in lung cancer treatment, including surgical improvements and chemotherapy regimens.
- Analysis of existing data on adjuvant chemotherapy efficacy across different lung cancer stages (IA, IB, II-IIIA).
Main Results:
- Adjuvant chemotherapy demonstrates clear benefits in Stage II-IIIA non-small cell lung cancer.
- Evidence suggests potential efficacy in Stage IB, while Stage IA data requires further validation in diverse populations.
- Optimal chemotherapy regimens and the role of targeted agents in the adjuvant setting are yet to be determined.
Conclusions:
- Further clinical trials are essential to establish optimal adjuvant chemotherapy regimens and the role of targeted therapies.
- Pharmacogenomic profiling and biomolecular marker identification are crucial for selecting patients who will benefit from individualized adjuvant treatments.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...